17α-estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site

Endocrinology

Volumn 153, Issue 7, 2012, Pages 3170-3178

  Yang, Qing ^a   Jian, Jinlong ^a   Katz, Stuart ^a   Abramson, Steven B ^a   Huang, Xi ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPCIDIN; IRON; LUCIFERASE; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; ORAL CONTRACEPTIVE AGENT; TRANSFERRIN RECEPTOR; ANTIMICROBIAL CATIONIC PEPTIDE; DNA; ESTROGEN;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IRON ABSORPTION; IRON BLOOD LEVEL; IRON STORAGE; IRON TRANSPORT; KNOCKOUT MOUSE; LIVER; MENSTRUATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; WILD TYPE; ANIMAL; CELL LINE; CHEMISTRY; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; GENE DELETION; GENETICS; METABOLISM; MOUSE MUTANT; PLASMID;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA; ESTRADIOL; ESTROGENS; FEMALE; GENE DELETION; HUMANS; IRON; MICE; MICE, KNOCKOUT; PLASMIDS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84862736353     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2045     Document Type: Article

References (47)

1. Imai Y, Kondoh S, Kouzmenko A, Kato S 2010 Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-α. Mol Endocrinol 24:877-885
2. Clemons M, Goss P 2001 Estrogen and the risk of breast cancer. N Engl J Med 344:276-285 (Pubitemid 32108534)
3. Huang X 2008 Does iron have a role in breast cancer? Lancet Oncol 9:803-807 (Pubitemid 352038319)
4. Jian J, Pelle E, Huang X 2009 Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 11:2939-2943
5. Hentze MW, Muckenthaler MU, Galy B, Camaschella C 2010 Two to tango: regulation of mammalian iron metabolism. Cell 142:24-38
6. Zimmermann MB, Hurrell RF 2007 Nutritional iron deficiency. Lancet 370:511-520 (Pubitemid 47214636)
7. Eckard J, Dai J, Wu J, Jian J, Yang Q, Chen H, Costa M, Frenkel K, Huang X 2010 Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis. Cancer Cell Int 10:28
8. Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J, Guth AA 2008 Breast cancer in young women. J Am Coll Surg 206:1193-1203
9. Gabriel CA, Domchek SM 2010 Breast cancer in young women. Breast Cancer Res 12:212
10. Yang Q, Jian J, Abramson SB, Huang X 2011 Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J Bone Miner Res 26:1188-1196
11. Viatte L, Vaulont S 2009 Hepcidin, the iron watcher. Biochimie 91:1223-1228
12. Nemeth E, Ganz T 2006 Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26:323-342
13. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y 2006 Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131:788-796 (Pubitemid 44316823)
14. Ganz T 2011 Hepcidin and iron regulation, 10 years later. Blood 117:4425-4433
15. Truksa J, Lee P, Peng H, Flanagan J, Beutler E 2007 The distal location of the iron responsive region of the hepcidin promoter. Blood 110:3436-3437 (Pubitemid 350106339)
16. Zeleniuch-Jacquotte A, Zhang Q, Dai J, Shore RE, Arslan AA, Koenig KL, Karkoszka J, Afanasyeva Y, Frenkel K, Toniolo P, Huang X 2007 Reliability of serum assays of iron status in postmenopausal women. Ann Epidemiol 17:354-358 (Pubitemid 46629029)
17. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919 (Pubitemid 32685217)
18. Weisz A, Rosales R 1990 Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18:5097-5106
19. Watkins RJ, Read ML, Smith VE, Sharma N, Reynolds GM, Buckley L, Doig C, Campbell MJ, Lewy G, Eggo MC, Loubiere LS, Franklyn JA, Boelaert K, McCabe CJ 2010 Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Res 70:3739-3749
20. Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA 1995 Estradiol regulation of the human retinoic acid receptor α gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55:4999-5006
21. Mason CE, Shu FJ, Wang C, Session RM, Kallen RG, Sidell N, Yu T, Liu MH, Cheung E, Kallen CB 2010 Location analysis for the estrogen receptor-α reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements. Nucleic Acids Res 38:2355-2368
22. Das D, Peterson RC, Scovell WM 2004 High mobility group B proteins facilitate strong estrogen receptor binding to classical and halfsite estrogen response elements and relax binding selectivity. Mol Endocrinol 18:2616-2632 (Pubitemid 39482053)
23. Martini PG, Katzenellenbogen BS 2001 Regulation of prothymosin α gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs. Endocrinology 142:3493-3501 (Pubitemid 32681757)
24. DeNardo DG, Kim HT, Hilsenbeck S, Cuba V, Tsimelzon A, Brown PH 2005 Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogeninduced/activator protein-1-dependent genes. Mol Endocrinol 19:362-378 (Pubitemid 40223461)
25. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T 2004 IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-1276 (Pubitemid 39069926)
26. Dudley MW, Sheeler CQ, Wang H, Khan S 2000 Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: implications for their mechanism of action. Proc Natl Acad Sci USA 97:3696-3701 (Pubitemid 30183365)
27. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E 2005 Hepcidin in iron overload disorders. Blood 105:4103-4105 (Pubitemid 40656161)
28. Schiavon R, Benavides S, Oropeza G, Garza-Flores J, Recio R, Díaz-Sanchez V, Pérez-Palacios G 1988 Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive. Contraception 37:591-598
29. Dai J, Jian J, Bosland M, Frenkel K, Bernhardt G, Huang X 2008 Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status. Breast 17:172-179 (Pubitemid 351467953)
30. Poola I, Kiang JG 1994 The estrogen-inducible transferrin receptorlike membrane glycoprotein is related to stress-regulated proteins. J Biol Chem 269:21762-21769 (Pubitemid 24274818)
31. Teng CT, Beard C, Gladwell W 2002 Differential expression and estrogen response of lactoferrin gene in the female reproductive tract of mouse, rat, and hamster. Biol Reprod 67:1439-1449 (Pubitemid 35204920)
32. Stuckey R, Aldridge T, Lim FL, Moore DJ, Tinwell H, Doherty N, Davies R, Smith AG, Kimber I, Ashby J, Orphanides G, Moggs JG 2006 Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol Cell Endocrinol 253:22-29 (Pubitemid 43946565)
33. Vyhlidal C, Li X, Safe S 2002 Estrogen regulation of transferrin gene expression in MCF-7 human breast cancer cells. J Mol Endocrinol 29:305-317 (Pubitemid 36032670)
34. Casabellata G, Di Santolo M, Banfi G, Stel G, Gonano F, Cauci S 2007 Evaluation of iron deficiency in young women in relation to oral contraceptive use. Contraception 76:200-207 (Pubitemid 47248662)
35. Frassinelli-Gunderson EP, Margen S, Brown JR 1985 Iron stores in users of oral contraceptive agents. Am J Clin Nutr 41:703-712 (Pubitemid 15092877)
36. Milman N, Kirchhoff M 1992 Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin. Ann Hematol 64:22-27
37. Borràs M 1998 Hormone dependency of splenic iron stores in the rat: effect of oestrogens on the recuperation of reserves in ferrodeficient subjects. Lab Anim 32:290-297 (Pubitemid 28379169)
38. Haouari M, Haouari-Oukerro F, Alguemi C, Nagati K, Zouaghi H, Kamoun A 1994 Effects of oestradiol-17β on small intestine iron absorption and iron uptake into blood and liver. Horm Metab Res 26:53-54
39. Robertson LS, Iwanowicz LR, Marranca JM 2009 Identification of centrarchid hepcidins and evidence that 17&beta-estradiol disrupts constitutive expression of hepcidin-1 and inducible expression of hepcidin-2 in largemouth bass (Micropterus salmoides). Fish Shellfish Immunol 26:898-907
40. Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S 2010 Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 95:4743-4747
41. Mattace Raso G, Irace C, Esposito E, Maffettone C, Iacono A, Di Pascale A, Santamaria R, Colonna A, Meli R 2009 Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue. Biochem Pharmacol 78:1001-1007
42. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D 2005 Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106:1864-1866 (Pubitemid 41208606)
43. Camberlein E, Abgueguen E, Fatih N, Canonne-Hergaux F, Leroyer P, Turlin B, Ropert M, Brissot P, Loréal O 2010 Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload. Biochim Biophys Acta 1802:339-346
44. Andrews NC 1999 Disorders of iron metabolism. N Engl J Med 341:1986-1995 (Pubitemid 30010408)
45. Masson C 2011 Rheumatoid anemia. Joint Bone Spine 78:131-137
46. Gao J, Chen J, De Domenico I, Koeller DM, Harding CO, Fleming RE, Koeberl DD, Enns CA 2010 Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood 115:3374-3381
47. Morán-Jiménez MJ, Méndez M, Santiago B, Rodríguez-García ME, Moreno-Carralero MI, Sánchez- Lucío AC, Grau M, Enríquez-de-Salamanca R 2010 Hepcidin treatment in Hfe-/- mice diminishes plasma iron without affecting erythropoiesis. Eur J Clin Invest 40:511-517